Cargando…

Reduction of depressive symptoms among patients with inflammatory bowel disease treated with biological therapy: A cross sectional study

INTRODUCTION: Previous studies suggest that one of the possible depression pathophysiological pathways is autoimmune inflammation increasing inflammatory mediators’ levels and thus affecting mood. OBJECTIVES: To compare depression and anxiety symptoms among inflammatory bowel disease patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zinkeviciute, J., Strumila, R., Dlugauskas, E., Brasiskiene, S., Kiziela, A., Ambrasas, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470974/ http://dx.doi.org/10.1192/j.eurpsy.2021.901

Ejemplares similares

Significant Association Between Huntingtin Gene Mutation and Prevalence of Hopelessness, Depression and Anxiety Symptoms
por: Butėnaitė, Adelė, et al.
Publicado: (2021)

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
por: Sochal, M., et al.
Publicado: (2021)

Symptoms of depression and anxiety in adolescents and their caregivers: A cross-sectional study from North Macedonia
por: Kunovski, I., et al.
Publicado: (2023)

Depressive Symptoms, Help-Seeking, and Barriers to Mental Healthcare Among Healthcare Professionals in Lithuania
por: Rogoža, Daniel, et al.
Publicado: (2021)

Fr503 FEAR OF COVID-19, ALONG WITH STRESS, ANXIETY, AND DEPRESSION, IS ASSOCIATED WITH BIOLOGIC USAGE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Shah, Rishabh, et al.
Publicado: (2021)

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
por: McIntyre, R. S., et al.
Publicado: (2023)

Basal and LPS-stimulated inflammatory markers and the course of depression and anxiety symptoms
por: Van Eeden, W. A.
Publicado: (2023)

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Krynicki, Carl, et al.
Publicado: (2018)

Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
por: Lee, Jung Won
Publicado: (2017)

Clinical consensus regarding the importance of rapid reduction in depressive symptoms in major depressive disorder with acute suicidal ideation or behavior (MDSI)
por: Borentain, S., et al.
Publicado: (2022)

Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
por: Milo, F., et al.
Publicado: (2023)

Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression and anxiety
por: Van Eeden, W.
Publicado: (2022)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
por: Deyhim, Tina, et al.
Publicado: (2023)

Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease
por: Gao, Xin, et al.
Publicado: (2021)

The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2023)

The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study
por: Mokros, Łukasz, et al.
Publicado: (2021)

The intensity of coronavirus anxiety and its associations with depressive symptoms and burnout among Polish nurses and firefighters: a preliminary cross-sectional study
por: Sienkiewicz-Jarosz, H., et al.
Publicado: (2022)

755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018)

Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
por: Mcintyre, R., et al.
Publicado: (2022)

Clinical Depression, Depressive Symptoms, and Depressed Cognition in Caregiving Grandmothers
por: Burant, Christopher, et al.
Publicado: (2020)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

Sa571 EVALUATION OF MENTAL STATE AND CLINICAL SYMPTOMS OF CORONAVIRUS PANDEMIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Tani, Mizuki, et al.
Publicado: (2021)

The Impact of ECT on mood symptoms: 50 patients were assessed using Hamilton Depression rating scale at the start, mid point and end of ECT. These results showed a clear reduction in depression symptoms as ECT progressed.
por: Collins, D.
Publicado: (2023)

Chronic inflammatory bowel diseases and sexuality: Inevitable disorders?
por: Charfi, N., et al.
Publicado: (2021)

Mo1055: COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASES IN SEQUENCIAL BIOLOGICAL TREATMENT
por: Baik, Deborah, et al.
Publicado: (2022)

Influence of smoking reduction on depressive and anxiety symptoms and quality of life in smokers with type 2 diabetes: a study focusing on the role of gender
por: Tzartzas, K., et al.
Publicado: (2023)

Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
por: Krusiński, Adam, et al.
Publicado: (2021)

Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS
por: Lelong, Margaux, et al.
Publicado: (2022)

Inflammatory bowel disease—the role of cross-sectional imaging techniques in the investigation of the small bowel
por: Athanasakos, Athanasios, et al.
Publicado: (2014)

Depression and anxiety among diabetics in primary care : a cross-sectional study
por: Omezzine, R. Gniwa, et al.
Publicado: (2021)

Anxiety, depression and tinnitus: a cross-sectional study about 60 cases
por: Karoui, M., et al.
Publicado: (2022)

Physical activity and depression later in life: a cross sectional study in Greece
por: Argyropoulos, K., et al.
Publicado: (2023)

Anxiety and depressive symptoms in patients with psoriasis
por: Sallemi, R., et al.
Publicado: (2021)

Anhedonia. Depressive versus negative symptom
por: Reynolds De Sousa, T., et al.
Publicado: (2022)

Ultrasonography in pediatric inflammatory bowel diseases
por: Massimetti, Mauro, et al.
Publicado: (2014)

27. Brief Office Interventions for Anxiety and Depression: Treating the Cause Rather Than the Symptoms
por: Schubiner, Howard
Publicado: (2013)

Inflammatory bowel disease cross‐sectional imaging: What's new?
por: Wang, Yang‐di, et al.
Publicado: (2022)

Cross-National Analysis of Bereavement From COVID-19 and Depressive Symptoms Among Older Adults in Europe
por: Wang, Haowei, et al.
Publicado: (2021)

Is even a probable premenstrual dysphoric disorder diagnosis associated with more severe anxio-depressive symptoms and lower well-being? A preliminary cross-sectional exploratory study
por: Kovács, I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u32mbh50i2vu29kgvbks4rjt7r